Extracorporeal photopheresis in acute and chronic graft-versus-host disease

Transfusion and Apheresis Science

Volumn 50, Issue 3, 2014, Pages 349-357

  Greinix, Hildegard T ^a   Worel, Nina ^a   Just, Ulrike ^b   Knobler, Robert ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

Author keywords

Extracorporeal photopheresis; Graft versus host disease

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APHERESIS; B LYMPHOCYTE; CHRONIC GRAFT VERSUS HOST DISEASE; CORTICOSTEROID REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE; CORTICOSTEROID REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE; EXTRACORPOREAL PHOTOPHERESIS; HUMAN; MORBIDITY; MORTALITY; PHASE 2 CLINICAL TRIAL (TOPIC); PREDICTION; PUVA; REVIEW; SURVIVAL RATE; TREATMENT RESPONSE; ACUTE DISEASE; ALLOGRAFT; CHRONIC DISEASE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; PROCEDURES;

ACUTE DISEASE; ALLOGRAFTS; CHRONIC DISEASE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PHOTOPHERESIS;

EID: 84926084066     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2014.04.005     Document Type: Review

References (67)

1. Greinix HT. In: Greinix HT, editor. Graft-versus-host disease. 1st ed. Bremen, Germany: UNI-MED Verlag; 2008.
2. Weiden P.L., Sullivan K.M., Flournoy N., Storb R., Thomas E.D. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981, 304:1529-1533.
3. Kuzmina Z., Eder S., Böhm A., Pernicka E., Vormittag L., Kalhs P., et al. Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study. Leukemia 2012, 26:746-756.
4. Horowitz M.M., Gale R.P., Sondel P.M., Goldman J.M., Kersey J., Kolb H.J., et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990, 75:555-562.
5. Marmont A.M., Horowitz M.M., Gale R.P., Sobocinski K., Ash R.C., van Bekkum D.W., et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991, 78:2120-2130.
6. Ram R., Gafter-Gvili A., Yeshurun M., Paul M., Raanani P., Shpilberg O. Prophylaxis regimens for GVHD: systematic review and meta-analysis. Bone Marrow Transplant 2009, 43:643-653.
7. Cutler C., Antin J.H. Novel drugs for the prevention and treatment of acute GVHD. Curr Pharm Des 2008, 14:1962-1973.
8. Greinix H.T., Socie G., Bacigalupo A., Holler E., Edinger M.G., Apperley J.F., et al. Assessing the potential role of photopheresis in hematopoietic stem cell transplant. Bone Marrow Transplant 2006, 38:265-273.
9. Shaughnessy P.J., Bolwell B.J., van Besien K., Mistrik M., Grigg A., Dodds A., et al. Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2010, 45:1068-1076.
10. Knobler R., Barr M.L., Couriel D.R., Ferrara J.L., French L.E., Jaksch P., et al. Extracorporeal photopheresis: past, present, and future. J Am Acad Dermatol 2009, 61:652-665.
11. Ferrara J.L., Levine J.E., Reddy P., Holler E. Graft-versus-host disease. Lancet 2009, 373:1550-1561.
12. Martin P.J., Rizzo J.D., Wingard J.R., Ballen K., Curtin P.T., Cutler C., et al. First and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American society of blood and marrow transplantation. Biol Blood Marrow Transplant 2012, 18:1150-1163.
13. Wolff D., Ayuk F., Elmaagacli A., Bertz H., Lawitschka A., Schleuning M., et al. Current practice in diagnosis and treatment of acute graft-versus-host disease - results from a survey among German-Austrian-Swiss HSCT centers. Biol Blood Marrow Transplant 2013, 19:767-776.
14. Salvaneschi L., Perotti C., Zecca M., Bernuzzi S., Viarengo G., Giorgiani G., et al. Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion 2001, 41:1299-1305.
15. Dall'Amico R., Messina C. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Ther Apheresis 2002, 6:296-304.
16. Messina C., Locatelli F., Lanino E., Uderzo C., Zacchello G., Cesaro S., et al. Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. Br J Haematol 2003, 122:118-127.
17. Greinix H.T., Knobler R.M., Worel N., Schneider B., Schneeberger A., Hoecker P., et al. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Haematologica 2006, 91:405-408.
18. Greinix H.T., Worel N., Knobler R. Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant 2010, 16:1747-1748.
19. Garban F., Drillat P., Makowski C., Jacob M.C., Richard M.J., Favrot M., et al. Extracorporeal chemophototherapy for the treatment of graft-versus-host disease: hematologic consequences of short-term, intensive courses. Haematologica 2005, 90:1096-1101.
20. Kanold J., Merlin E., Halle P., Paillard C., Marabelle A., Rapatel C., et al. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature. Transfusion 2007, 47:2276-2289.
21. Calore E., Calo A., Tridello G., Cesaro S., Pillon M., Varotto S., et al. Extracorporeal photochemotherapy may improve outcome in children with acute GVHD. Bone Marrow Transplant 2008, 42:421-425.
22. Perfetti P., Carlier P., Strada P., Gualandi F., Occhini D., Van Lint M.T., et al. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD. Bone Marrow Transplant 2008, 42:609-617.
23. Gonzalez-Vicent M., Ramirez M., Perez A., Lassaletta A., Sevilla J., Diaz M.A. Extracorporeal photochemotherapy for steroid-refractory graft-versus-host disease in low-weight pediatric patients. Immunomodulatory effects and clinical outcome. Haematologica 2008, 93:1278-1280.
24. Perotti C., Del F.C., Tinelli C., Viarengo G., Scudeller L., Zecca M., et al. Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients. Transfusion 2010, 50:1359-1369.
25. Greinix H.T., Volc-Platzer B., Kalhs P., Fischer G., Rosenmayr A., Keil F., et al. Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. Blood 2000, 96:2426-2431.
26. Jagasia M., Greinix H., Robin M., Das-Gupta E., Jacobs R., Savani B.N., et al. Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid refractory acute GVHD: a multicenter comparative analysis. Biol Blood Marrow Transplant 2013, 19:1124-1135.
27. Dignan F.L., Clark A., Amrolia P., Cornish J., Jackson G., Mahendra P., et al. Diagnosis and management of acute graft-versus-host disease. Br J Haematol 2012, 158:30-45.
28. Pierelli L, Perseghin P, Marchetti M, Messina C, Perotti C, Mazzoni A, et al. Extracorporeal photopheresis for the treatment of acute and chronic graft-versus-host disease in adults and children: best practice recommendations from an Italian society of hemapheresis and cell manipulation (SIdEM) and Italian group for bone marrow transplantation (GITMO) consensus process. Transfusion published online 10.01.2013. [doi: 10.1111/trf.12059].
29. European Dermatology Forum. Guideline on extracorporeal photopheresis. http://www.euroderm.org/index.php/edf-guidelines.
30. Flowers M.E., Inamoto Y., Carpenter P.A., Lee S.J., Kiem H.P., Petersdorf E.W., et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to national institutes of health consensus criteria. Blood 2011, 117:3214-3219.
31. Schultz K.R. Pathophysiology of chronic graft versus host disease. Chronic graft versus host disease 2009, 17-30. Cambridge University Press, Cambridge, United Kingdom. G.B. Vogelsang, S.Z. Pavletic (Eds.).
32. Kuzmina Z., Greinix H.T., Weigl R., Körmöczi U., Rottal A., Frantal S., et al. Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease associated dysgammaglobulinemia. Blood 2011, 117:2265-2274.
33. Weinberg K., Blazar B.R., Wagner J.E., Agura E., Hill B.J., Smogorzewska M., et al. Factors affecting thymic function after allogeneic stem cell transplantation. Blood 2001, 97:1458-1466.
34. Filipovich A.H., Weisdorf D., Pavletic S., Socie G., Wingard J.R., Lee S.J., et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
35. Wolff D., Gerbitz A., Ayuk F., Kiani A., Hildebrandt G.C., Vogelsang G.B., et al. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. Biol Blood Marrow Transplant 2010, 16:1611-1628.
36. Flowers M.E., Parker P.M., Johnston L.J., Matos A.V., Storer B., Bensinger W.I., et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized tiral. Blood 2002, 100:415-419.
37. Wolff D., Schleuning M., van Harsdorf S., Bacher U., Gerbitz A., Stadler M., et al. Consensus conference on clinical practice in chronic GVHD: second line treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2011, 17:1-17.
38. Martin P.J., Inamoto Y., Carpenter P.A., Lee S.J., Flowers M.E.D. Treatment of chronic graft-versus-host disease: past, present and future. Korean J Hematol 2011, 46:153-163.
39. Greinix H.T., Volc-Platzer B., Rabitsch W., Gmeinhart B., Guevara-Pineda C., Kalhs P., et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 1998, 92:3098-3104.
40. Child F.J., Ratnavel R., Watkins P., Samson D., Apperley J., Ball J., et al. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 1999, 23:881-887.
41. Seaton E.D., Szydlo R.M., Kanfer E., Apperley J.F., Russell-Jones R. Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. Blood 2003, 102:1217-1223.
42. Apisarnthanarax N., Donato M., Korbling M., Couriel D., Gajewski J., Giralt S., et al. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplant 2003, 31:459-465.
43. Foss F.M., DiVenuti G.M., Chin K., Sprague K., Grodman H., Klein A., et al. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant 2005, 35:1187-1193.
44. Rubegni P., Cuccia A., Sbano P., Cevenini G., Carcagni M.R., D'Ascenzo G., et al. Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease. Br J Haematol 2005, 130:271-275.
45. Bisaccia E., Palangio M., Gonzalez J., Adler K.R., Scarborough R., Goldberg S.L., et al. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy. J Clin Apheresis 2006, 21:181-187.
46. Couriel D.R., Hosing C., Saliba R., Shpall E.J., Anderlini P., Rhodes B., et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 2006, 107:3074-3080.
47. Perseghin P., Galimberti S., Balduzzi A., Bonanomi S., Baldini V., Rovelli A., et al. Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect?. Ther Apheresis Dialysis 2007, 11:85-93.
48. Flowers M.E., Apperley J.F., van Besien K., Elmaagacli A., Grigg A., Reddy V., et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood 2008, 112:2667-2674.
49. Jagasia M.H., Savani B.N., Stricklin G., Engelhardt B., Kassim A., Dixon S., et al. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biol Blood Marrow Transplant 2009, 15:1288-1295.
50. Dignan F.L., Greenblatt D., Cox M., Cavenagh J., Oakervee H., Apperley J.F., et al. Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD. Bone Marrow Transplant 2012, 47:824-830.
51. Greinix H.T., van Besien K., Elmaagacli A.H., Hillen U., Grigg A., Knobler R., et al. Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis - results of a crossover randomized study. Biol Blood Marrow Transplant 2011, 17:1775-1782.
52. Del Fante C., Scudeller L., Viarengo G., Bernasconi P., Perotti C. Response and survival of patients with chronic graft-versus-host disease treated by extracorporeal photochemotherapy: a retrospective study according to classical and national institutes of health classifications. Transfusion 2012, 52:2007-2015.
53. Hautmann A.H., Wolff D., Hahn J., Edinger M., Schirmer N., Ammer J., et al. Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: results of treatment with the COBE Spectra system. Bone Marrow Transplant 2013, 48:439-445.
54. Lucid C.E., Savani B.N., Engelhardt B.G., Shah P., Clifton C., Greenhut S.L., et al. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT. Bone Marrow Transplant. 2011, 46:426-429.
55. Suchin K.R., Cassin M., Washko R., Nahass G., Berkson M., Stouch B., et al. Extracorporeal photochemotherapy does not suppress T- or B-cell responses to novel or recall antigens. J Am Acad Dermatol 1999, 41:980-986.
56. Kanold J., Messina C., Halle P., Locatelli F., Lanino E., Cesaro S., et al. Update on extracorporeal photochemotherapy for graft-versus-host disease treatment. Bone Marrow Transplant 2005, 35(Suppl 1):S69-S71.
57. - B lymphocytes predict the response to extracorporeal photopheresis in patients with chronic graft-versus-host disease. Blood 2009, 114:744-746.
58. Tangye S.G., Bryant V.L., Cuss A.K., Good K.L. BAFF, April and human B cell disorders. Semin Immunol 2006, 18:305-317.
59. Sarantopoulos S., Stevenson K.E., Kim H.T., Cutler C.S., Bhulya N.S., Schowalter M., et al. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. Blood 2009, 113:3865-3874.
60. low B-cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome. Blood 2013, 121:1886-1895.
61. Whittle R., Taylor P.C. Circulating B-cell activating factor level predicts clinical response of chronic graft-versus-host disease to extracorporeal photopheresis. Blood 2011, 118:6446-6449.
62. Edinger M., Hoffmann P., Ermann J., Drago K., Fathman C.G., Strober S., et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003, 9:1144-1150.
63. Maeda A., Schwarz A., Kernebeck K., Gross N., Aragane Y., Peritt D., et al. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 2005, 174:5968-5976.
64. Gatza E., Rogers C.E., Clouthier S.G., Lowler K.P., Tawara I., Liu C., et al. Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood 2008, 112:1515-1521.
65. Biagi E., Di Biaso I., Leoni V., Gaipa G., Rossi V., Bugarin C., et al. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 2007, 84:31-39.
66. Di Biasio I., Di Maio L., Bugarin C., Gaipa G., Dander E., Balduzzi A., et al. Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. Transplantation 2009, 87:1422-1425.
67. Dignan F.L., Amrolia P., Clark A., Cornish J., Jackson G., Mahendra P., et al. Diagnosis and management of chronic graft-versus-host disease. Br J Haematol 2012, 158:46-61.